Remidex Pharma Private Limited

Remidex Pharma Private Limited - pharma in Bengaluru, Karnataka, India. FY 2026 financials & compliance.
CIN U24231KA1981PTC004260 Incorporated 15 June 1981 ROC Bangalore HQ Bengaluru, Karnataka, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹24.56 Cr
▼ 22% YoY
Net loss · FY 2025
₹1.34 Cr
Net margin -5.4%
EBITDA · FY 2025
-₹3.64 Lakh
EBITDA margin -0.1%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹3 Cr
Issued & subscribed
Open charges
₹4 Cr
Satisfied ₹15.26 Cr
Company age
45 yrs
Est. 1981
Employees · EPFO
123
Provident fund records

About Remidex Pharma Private Limited

Data last updated:

Remidex Pharma Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 June 1981 and has been in existence for over 45 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24231KA1981PTC004260. Its GSTIN is 29AAACR7006C1ZP (Karnataka).

The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹3 Cr. It is led by directors including Nilima Dayanand Rao (Managing Director) and Ishaan Pejavar Rao.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 249 250 147&148 6th Main 2nd Stage Peenya Industrial Estate, Bengaluru, Karnataka, India – 560058.

As per the financials filed for FY 2025, the company reported a revenue of ₹24.56 Cr, a decline of 22% compared to the previous year. For the same year it recorded a net loss of ₹1.34 Cr (net margin -5.4%) and EBITDA of -₹3.64 Lakh (EBITDA margin -0.1%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years and 8% over five years.

The company has about 123 employees on its provident fund (EPFO) records.

The company is associated with 2 brands: Remidex Pharma and Humbing Ethicals. As per MCA filings, the company has open charges of ₹4 Cr and satisfied charges of ₹15.26 Cr on record. Court records list 27 cases involving the company, including 8 filed by the company and 19 filed against it; 4 cases are pending. The company has 4 deals on record (4 secondary share transfers); the latest was in March 2020. Its 7 peer companies in the Pharma industry (Contract Research, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is Evinz Drugs Private Limited with revenue of ₹24.63 Cr. The company has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 22 overdue payments to 9 micro and small suppliers.

Remidex Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0070581). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website remidexpharma.com.

Company details

CIN U24231KA1981PTC004260
Registration Number 004260
Incorporation Date 15 June 1981
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-KR-03-0070581

CIN history

Remidex Pharma has one previous CIN (Corporate Identification Number): U02423KA1981PTC004260. The current CIN is U24231KA1981PTC004260, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24231KA1981PTC004260Current
U02423KA1981PTC004260Previous
Key People
Nilima Dayanand Rao Managing Director Ishaan Pejavar Rao Director Nandan Pejavar Rao Director

Recognitions & Rankings of Remidex Pharma

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-KR-03-0070581

Contact details

Remidex Pharma Private Limited's registered office is in Bengaluru, Karnataka. Its website is remidexpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    remidexpharma.com
  • Social Media
  • Registered Address
    B – 249 250 147&148 6th Main 2nd Stage Peenya Industrial Estate, Bengaluru, Karnataka, India – 560058
  • Industry
    Pharma, Drug Formulation & Development, Pharma Contract R&D

To see the full contact details of Remidex Pharma Private Limited, buy the company report.

Comprehensive company report
Remidex Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Remidex Pharma operates two associated brands: Remidex Pharma and Humbing Ethicals. Each brand links to its own profile.

BrandDescriptionWebsite
Remidex Pharma
Manufactures high-quality pharmaceutical and nutraceutical products, including tablets, capsules, liquids, and premixes.remidexpharma.com
Humbing Ethicals
Potato farming, grain marketing, and equipment services in Maine.humbingethicals.com

Business activity

The main business activity of Remidex Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Remidex Pharma Private Limited, buy the company report.

Financials of Remidex Pharma Private Limited

FY 2025 filings available

Remidex Pharma Private Limited reported revenue of ₹24.56 Cr (down 22% YoY) for FY 2025.

Revenue · FY 2025
₹24.56 Cr ▼ 22%
Net loss · FY 2025
₹1.34 Cr margin -5.4%
EBITDA · FY 2025
-₹3.64 Lakh margin -0.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 22%
3 years · compounded
▲ 11%
5 years · compounded
▼ 8%
EBITDA CAGR growth
1 year
▲ 88%
3 years · compounded
▲ 65%
5 years · compounded
▲ 54%

Revenue has declined at a compounded annual rate (CAGR) of 8% over five years, including a 22% fall in the latest year. EBITDA rose 88% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹3.64 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.34 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-0.1%
Net Profit Margin-5.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Remidex Pharma Private Limited, buy the company report.

Board of directors of Remidex Pharma Private Limited

Remidex Pharma has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ishaan Pejavar Rao
Also directs: Surima Ventures LLP, Ishaan Labs Private Limited, Sanil Pharmaceuticals Private Limited
Director24 Oct 20188 Years 0 MonthsCurrent
Nandan Pejavar Rao
Also directs: Surima Ventures LLP, Ishaan Labs Private Limited, Sanil Pharmaceuticals Private Limited
Director24 Oct 20188 Years 0 MonthsCurrent
Nilima Dayanand Rao
Also directs: Surima Ventures LLP, Ishaan Labs Private Limited, Sanil Pharmaceuticals Private Limited
Managing Director24 Jan 20179 Years 9 MonthsCurrent
View all directors

Peer comparison

Remidex Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Contract Research, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Evinz Drugs Private Limited₹24.63 Cr (FY 2020)5.0%Hyderabad, Telangana, India
Vats Biotech Private Limited₹24.62 Cr (FY 2025)13.0%Jamshedpur, Jharkhand, India
Pharlink Labs Private Limited₹24.56 Cr (FY 2024)111.0%Chennai, Tamil Nadu, India
Remidex Pharma Private Limitedthis company₹24.56 Cr (FY 2025)-₹1.34 Cr-5.4%-22.0%123Bengaluru, Karnataka, India
Carewell Steuart Pharma Private Limited₹24.5 Cr (FY 2025)79.0%Tiruvallur, Tamil Nadu, India
MRHM Pharma Private Limited₹24.46 Cr (FY 2024)10.0%Bangalore, Karnataka, India
Sunberg Life Sciences Private Limited₹24.43 Cr (FY 2025)92.0%Chennai, Tamil Nadu, India
Axon Drugs Private Limited₹24.4 Cr (FY 2024)4.0%Chennai, Tamil Nadu, India

To see the full peer comparison of Remidex Pharma Private Limited, buy the company report.

Auditor

Remidex Pharma Private Limited is audited by KIRTANE & PANDIT LLP for the financial year 2024.

Auditor firmFinancial yearFirm registration number
KIRTANE & PANDIT LLPFY 2024105215W/W100057

Shareholding

The shareholding of Remidex Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Remidex Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹4 Cr
Satisfied charges
₹15.26 Cr
Breakdown by lending institutions
Canara Bank₹4.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
16 Apr 200680047323Canara Bank₹4 CrOpen
21 Aug 2019100284218Others₹6 CrSatisfied
20 Jul 2018100241950Canara Bank₹31 LakhSatisfied
29 Jan 200580060409Kotak Mahindra Bank Ltd₹1.95 CrSatisfied
29 Jan 200580044051Kotak Mahindra Bank Limited₹3.35 CrSatisfied

To see the full charge records of Remidex Pharma Private Limited, buy the company report.

Total charge records: 9 View all charges

Deals & funding

Remidex Pharma Private Limited has 4 deals on record (4 secondary share transfers); the latest was in March 2020.

Total deals
4
Secondary share transfers
4

Deals on record (4 of 4)

WhenDealAmountParties
Mar 2020Secondary share transferUndisclosedBuyer: 3 individuals
Seller: an individual
Mar 2012Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Sep 2009Secondary share transferUndisclosedBuyer: 2 individuals
Seller: an individual
Nov 2008Secondary share transferUndisclosedBuyer: an individual
Seller: an individual

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Remidex Pharma Private Limited was last rated by Brickwork on 14 Mar 2022.

Rating agencyRated onRating
Brickwork14 Mar 2022

To see the full credit ratings and regulatory alerts of Remidex Pharma Private Limited, buy the company report.

MSME payment delays

Remidex Pharma Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 22 overdue payments to 9 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 9)

SupplierAmount dueDue sinceReported on
an individual supplier
an individual supplier
Award Packaging Private Limited
Karan Plascon Private Limited
Sunshine Organics Pvt Ltd

To see the full MSME payment records of Remidex Pharma Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Remidex Pharma Private Limited has a workforce of 123 employees on its EPFO records as of Mar 21, 2025, across 1 active EPFO establishment.

Employee count
123
Active EPFO establishments
1
Employee growth
-10.87%

GST

Remidex Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
29AAACR7006C1ZPKarnatakaActive01 Jul 2017

To see the full GST registrations and return filing status of Remidex Pharma Private Limited, buy the company report.

Recent activity

Remidex Pharma Private Limited has 12 board changes on record since 2008: 3 appointments and 9 cessations. The latest: Mohini Dayanand Rao ceased to be Director on 11 Jun 2020.

AGM
Remidex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Canara Bank of Rs. 4.00 Cr registered on 16 Apr 2006 with Charge ID 80047323 was modified on 09 Sep 2025.
Filing
Remidex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Charges
A charge registered on 20 Jul 2018 via Charge ID 100241950 with Canara Bank was fully satisfied on 20 Jan 2022.
Charges
A charge registered on 16 May 1998 via Charge ID 90191951 with Canara Bank was fully satisfied on 19 Jun 2020.
Charges
A charge registered on 14 Nov 1997 via Charge ID 90191869 with Canara Bank was fully satisfied on 19 Jun 2020.
Charges
A charge registered on 16 Nov 1986 via Charge ID 90193253 with Canara Bank was fully satisfied on 19 Jun 2020.
Charges
A charge registered on 21 Aug 2019 via Charge ID 100284218 with Others was fully satisfied on 11 Jun 2020.
Ceased
Mohini Dayanand Rao ceased to be Director.
Ceased
Ishaan Pejavar Rao ceased to be Additional Director.
Ceased
Nandan Pejavar Rao ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 6.00 Cr with Charge ID 100284218 was registered on 21 Aug 2019.

23 earlier events are in the company report.

Frequently asked questions

Remidex Pharma is an active private limited company based in Bengaluru, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 June 1981 (45+ years old) and is registered under CIN U24231KA1981PTC004260.

Remidex Pharma has 3 current directors:

The latest financial statements of Remidex Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Remidex Pharma is 29AAACR7006C1ZP, registered in Karnataka.

The CIN (Corporate Identification Number) of Remidex Pharma is U24231KA1981PTC004260. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Remidex Pharma has 27 court cases on record: 8 filed by the company and 19 filed against it. 4 are pending. Most are in the high courts.

Remidex Pharma was incorporated on 15 June 1981, making it 45+ years old. It is registered with the Registrar of Companies, Bangalore.

Remidex Pharma has 4 deals on record (4 secondary share transfers); the latest was in March 2020.

The peers of Remidex Pharma by revenue are Evinz Drugs Private Limited, Vats Biotech Private Limited, Pharlink Labs Private Limited, Carewell Steuart Pharma Private Limited, MRHM Pharma Private Limited and 2 more, all in the Pharma industry (Contract Research, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Mohini Dayanand Rao ceased to be Director on 11 Jun 2020. Ishaan Pejavar Rao ceased to be Additional Director on 24 Sep 2019. Nandan Pejavar Rao ceased to be Additional Director on 24 Sep 2019. Remidex Pharma has 12 board changes on record in total.

Yes, Remidex Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-KR-03-0070581).

Remidex Pharma has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 22 overdue payments to 9 micro and small suppliers. The latest return was filed on 30 May 2019.